

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GDP-mannose metabolic process (GO:0019673) | 5.34518512 |
| 2 | DNA strand elongation involved in DNA replication (GO:0006271) | 5.15872253 |
| 3 | mannose metabolic process (GO:0006013) | 5.02086790 |
| 4 | ribosomal small subunit assembly (GO:0000028) | 4.97897358 |
| 5 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.92933271 |
| 6 | DNA strand elongation (GO:0022616) | 4.90945491 |
| 7 | DNA deamination (GO:0045006) | 4.82940241 |
| 8 | maturation of SSU-rRNA (GO:0030490) | 4.77567729 |
| 9 | DNA replication initiation (GO:0006270) | 4.69564653 |
| 10 | nucleobase biosynthetic process (GO:0046112) | 4.54395631 |
| 11 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.51384267 |
| 12 | DNA unwinding involved in DNA replication (GO:0006268) | 4.48017760 |
| 13 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.39925213 |
| 14 | telomere maintenance via recombination (GO:0000722) | 4.31840673 |
| 15 | formation of translation preinitiation complex (GO:0001731) | 4.30191222 |
| 16 | purine nucleobase biosynthetic process (GO:0009113) | 4.29970823 |
| 17 | intracellular estrogen receptor signaling pathway (GO:0030520) | 4.29462492 |
| 18 | viral transcription (GO:0019083) | 4.25237663 |
| 19 | DNA replication checkpoint (GO:0000076) | 4.22408037 |
| 20 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 4.22205099 |
| 21 | translational termination (GO:0006415) | 4.19715485 |
| 22 | ribosomal large subunit biogenesis (GO:0042273) | 4.16480304 |
| 23 | mitotic recombination (GO:0006312) | 4.10269643 |
| 24 | apoptotic process involved in morphogenesis (GO:0060561) | 4.00201187 |
| 25 | proline biosynthetic process (GO:0006561) | 3.96592544 |
| 26 | ribosomal small subunit biogenesis (GO:0042274) | 3.91824543 |
| 27 | translational elongation (GO:0006414) | 3.88028010 |
| 28 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.87358052 |
| 29 | telomere maintenance via telomere lengthening (GO:0010833) | 3.87148713 |
| 30 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.86695320 |
| 31 | IMP biosynthetic process (GO:0006188) | 3.86581772 |
| 32 | negative regulation of cell size (GO:0045792) | 3.85489909 |
| 33 | ribosome biogenesis (GO:0042254) | 3.83152777 |
| 34 | proteasome assembly (GO:0043248) | 3.80043221 |
| 35 | translational initiation (GO:0006413) | 3.79545754 |
| 36 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.70259310 |
| 37 | pseudouridine synthesis (GO:0001522) | 3.69421034 |
| 38 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.67188460 |
| 39 | negative regulation of telomerase activity (GO:0051974) | 3.66840573 |
| 40 | regulation of translational fidelity (GO:0006450) | 3.66226935 |
| 41 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.65669961 |
| 42 | protein localization to kinetochore (GO:0034501) | 3.65362732 |
| 43 | UV protection (GO:0009650) | 3.62993033 |
| 44 | spliceosomal snRNP assembly (GO:0000387) | 3.60154573 |
| 45 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.59289978 |
| 46 | CENP-A containing nucleosome assembly (GO:0034080) | 3.58087130 |
| 47 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.57616282 |
| 48 | ribosome assembly (GO:0042255) | 3.56089257 |
| 49 | thymic T cell selection (GO:0045061) | 3.55975169 |
| 50 | rRNA processing (GO:0006364) | 3.55482940 |
| 51 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.55199345 |
| 52 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.55199345 |
| 53 | chromatin remodeling at centromere (GO:0031055) | 3.52445665 |
| 54 | mitotic metaphase plate congression (GO:0007080) | 3.51438570 |
| 55 | cotranslational protein targeting to membrane (GO:0006613) | 3.49870075 |
| 56 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.49640856 |
| 57 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.49542726 |
| 58 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.47839957 |
| 59 | protein targeting to ER (GO:0045047) | 3.47468104 |
| 60 | mitotic nuclear envelope disassembly (GO:0007077) | 3.46996155 |
| 61 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.46830990 |
| 62 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.45161461 |
| 63 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.44922669 |
| 64 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.43230791 |
| 65 | rRNA metabolic process (GO:0016072) | 3.42748860 |
| 66 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.40101403 |
| 67 | regulation of chromatin binding (GO:0035561) | 3.40087056 |
| 68 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.39073937 |
| 69 | Golgi transport vesicle coating (GO:0048200) | 3.34883037 |
| 70 | COPI coating of Golgi vesicle (GO:0048205) | 3.34883037 |
| 71 | cellular protein complex disassembly (GO:0043624) | 3.32898268 |
| 72 | positive regulation of synapse maturation (GO:0090129) | 3.32135702 |
| 73 | protein insertion into membrane (GO:0051205) | 3.32120871 |
| 74 | IMP metabolic process (GO:0046040) | 3.32014491 |
| 75 | histone H4 deacetylation (GO:0070933) | 3.31623241 |
| 76 | positive regulation of histone deacetylation (GO:0031065) | 3.30471448 |
| 77 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.30234876 |
| 78 | DNA replication-independent nucleosome organization (GO:0034724) | 3.29496087 |
| 79 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.29496087 |
| 80 | modulation by virus of host process (GO:0019054) | 3.28253702 |
| 81 | protein localization to endoplasmic reticulum (GO:0070972) | 3.28150360 |
| 82 | viral life cycle (GO:0019058) | 3.27409887 |
| 83 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.27106861 |
| 84 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.26741153 |
| 85 | negative regulation of ligase activity (GO:0051352) | 3.26741153 |
| 86 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.25734910 |
| 87 | folic acid metabolic process (GO:0046655) | 3.25557726 |
| 88 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.21734105 |
| 89 | * snRNA metabolic process (GO:0016073) | 3.18879071 |
| 90 | protein localization to chromosome, centromeric region (GO:0071459) | 3.17137918 |
| 91 | negative regulation of myotube differentiation (GO:0010832) | 3.17095768 |
| 92 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.16443731 |
| 93 | membrane disassembly (GO:0030397) | 3.16283405 |
| 94 | nuclear envelope disassembly (GO:0051081) | 3.16283405 |
| 95 | activation of MAPKKK activity (GO:0000185) | 3.16245455 |
| 96 | metaphase plate congression (GO:0051310) | 3.15426340 |
| 97 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 3.14042780 |
| 98 | negative regulation of viral release from host cell (GO:1902187) | 3.13040248 |
| 99 | G1/S transition of mitotic cell cycle (GO:0000082) | 3.12459817 |
| 100 | cell cycle G1/S phase transition (GO:0044843) | 3.12459817 |
| 101 | translation (GO:0006412) | 3.11826046 |
| 102 | histone H3 deacetylation (GO:0070932) | 3.10859663 |
| 103 | regulation of ARF GTPase activity (GO:0032312) | 3.10656932 |
| 104 | activation of Rac GTPase activity (GO:0032863) | 3.10577650 |
| 105 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.09348650 |
| 106 | positive regulation of gene expression, epigenetic (GO:0045815) | 3.07842670 |
| 107 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.06479282 |
| 108 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.06479282 |
| 109 | cellular response to virus (GO:0098586) | 3.06465601 |
| 110 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.06245120 |
| 111 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.06245120 |
| 112 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.06245120 |
| 113 | positive thymic T cell selection (GO:0045059) | 3.06011329 |
| 114 | ncRNA 3-end processing (GO:0043628) | 3.04944083 |
| 115 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.04692006 |
| 116 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.04692006 |
| 117 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.03978479 |
| 118 | termination of RNA polymerase III transcription (GO:0006386) | 3.03978479 |
| 119 | creatine metabolic process (GO:0006600) | 3.02940351 |
| 120 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.02832924 |
| 121 | protein complex disassembly (GO:0043241) | 3.01892097 |
| 122 | viral mRNA export from host cell nucleus (GO:0046784) | 3.01708626 |
| 123 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.00720574 |
| 124 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.95740530 |
| 125 | telomere maintenance (GO:0000723) | 2.93983276 |
| 126 | telomere organization (GO:0032200) | 2.93812359 |
| 127 | semaphorin-plexin signaling pathway (GO:0071526) | 2.92823833 |
| 128 | iron-sulfur cluster assembly (GO:0016226) | 2.92731869 |
| 129 | metallo-sulfur cluster assembly (GO:0031163) | 2.92731869 |
| 130 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.92588070 |
| 131 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.92571850 |
| 132 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.92204752 |
| 133 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.92204752 |
| 134 | proline metabolic process (GO:0006560) | 2.91513147 |
| 135 | histone arginine methylation (GO:0034969) | 2.91234395 |
| 136 | cellular component biogenesis (GO:0044085) | 2.91143038 |
| 137 | protein-DNA complex disassembly (GO:0032986) | 2.90085546 |
| 138 | nucleosome disassembly (GO:0006337) | 2.90085546 |
| 139 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.90039380 |
| 140 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.89947251 |
| 141 | retrograde transport, endosome to Golgi (GO:0042147) | 2.89288099 |
| 142 | spliceosomal complex assembly (GO:0000245) | 2.88785839 |
| 143 | macromolecular complex disassembly (GO:0032984) | 2.88628434 |
| 144 | histone exchange (GO:0043486) | 2.88465135 |
| 145 | protein retention in ER lumen (GO:0006621) | 2.88102127 |
| 146 | DNA duplex unwinding (GO:0032508) | 2.85810232 |
| 147 | NIK/NF-kappaB signaling (GO:0038061) | 2.85145567 |
| 148 | DNA geometric change (GO:0032392) | 2.84246299 |
| 149 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 2.83341541 |
| 150 | positive regulation of ligase activity (GO:0051351) | 2.82775311 |
| 151 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.82772358 |
| 152 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.82434325 |
| 153 | establishment of chromosome localization (GO:0051303) | 2.81987474 |
| 154 | adherens junction assembly (GO:0034333) | 2.80399924 |
| 155 | rRNA modification (GO:0000154) | 2.79901989 |
| 156 | * ncRNA processing (GO:0034470) | 2.79217006 |
| 157 | negative regulation of B cell apoptotic process (GO:0002903) | 2.78408354 |
| 158 | heterochromatin organization (GO:0070828) | 2.75242548 |
| 159 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.73595014 |
| 160 | * snRNA processing (GO:0016180) | 2.72705905 |
| 161 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.72256542 |
| 162 | modulation by symbiont of host cellular process (GO:0044068) | 2.69867225 |
| 163 | peptidyl-arginine methylation (GO:0018216) | 2.69760404 |
| 164 | peptidyl-arginine N-methylation (GO:0035246) | 2.69760404 |
| 165 | positive regulation of protein dephosphorylation (GO:0035307) | 2.69249229 |
| 166 | 2-oxoglutarate metabolic process (GO:0006103) | 2.66416619 |
| 167 | focal adhesion assembly (GO:0048041) | 2.66313009 |
| 168 | cell-substrate adherens junction assembly (GO:0007045) | 2.66313009 |
| 169 | positive regulation of protein deacetylation (GO:0090312) | 2.66312424 |
| 170 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.65068130 |
| 171 | apoptotic process involved in development (GO:1902742) | 2.63947285 |
| 172 | endothelial cell chemotaxis (GO:0035767) | 2.63337104 |
| 173 | atrioventricular valve morphogenesis (GO:0003181) | 2.61681835 |
| 174 | positive regulation of protein kinase C signaling (GO:0090037) | 2.61451385 |
| 175 | DNA damage induced protein phosphorylation (GO:0006975) | 2.61364452 |
| 176 | entrainment of circadian clock by photoperiod (GO:0043153) | 2.59910270 |
| 177 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 2.58849298 |
| 178 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.58815589 |
| 179 | modulation by virus of host morphology or physiology (GO:0019048) | 2.58672462 |
| 180 | cellular response to interleukin-4 (GO:0071353) | 2.57663274 |
| 181 | cell-cell junction maintenance (GO:0045217) | 2.56681951 |
| 182 | regulation of telomerase activity (GO:0051972) | 2.55795936 |
| 183 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.55551725 |
| 184 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.54876150 |
| 185 | regulation of synapse maturation (GO:0090128) | 2.50794814 |
| 186 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.49843535 |
| 187 | response to interleukin-4 (GO:0070670) | 2.48818770 |
| 188 | mitotic chromosome condensation (GO:0007076) | 2.48254553 |
| 189 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.48198874 |
| 190 | mitotic G1/S transition checkpoint (GO:0044819) | 2.47106221 |
| 191 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.46815592 |
| 192 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.46577180 |
| 193 | regulation of histone H3-K27 methylation (GO:0061085) | 2.45503764 |
| 194 | oxaloacetate metabolic process (GO:0006107) | 2.43959180 |
| 195 | cell migration in hindbrain (GO:0021535) | 2.43810454 |
| 196 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.43417856 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.99290092 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.21375583 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.93639900 |
| 4 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.22736178 |
| 5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.17180592 |
| 6 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.12785385 |
| 7 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.05664219 |
| 8 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.01308554 |
| 9 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.96401217 |
| 10 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.96128826 |
| 11 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.93804993 |
| 12 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.88700639 |
| 13 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.84444749 |
| 14 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.79545715 |
| 15 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.71050570 |
| 16 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.69446925 |
| 17 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.52612122 |
| 18 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.40405602 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.36740803 |
| 20 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.36276438 |
| 21 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.31576261 |
| 22 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.31038530 |
| 23 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.25452497 |
| 24 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.24713630 |
| 25 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.19317328 |
| 26 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.14677559 |
| 27 | P68_20966046_ChIP-Seq_HELA_Human | 2.13812671 |
| 28 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.09358409 |
| 29 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.08740313 |
| 30 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.07532225 |
| 31 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.06598265 |
| 32 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.01230584 |
| 33 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.00855948 |
| 34 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.98566505 |
| 35 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.96613093 |
| 36 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.96212449 |
| 37 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.94347059 |
| 38 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.92843970 |
| 39 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.86322754 |
| 40 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.86028438 |
| 41 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.84934362 |
| 42 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.83868555 |
| 43 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.83427145 |
| 44 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.82820006 |
| 45 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.79867306 |
| 46 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.79034675 |
| 47 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76813249 |
| 48 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.76039673 |
| 49 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.73826822 |
| 50 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.73522223 |
| 51 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.73442225 |
| 52 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.73404381 |
| 53 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.72543136 |
| 54 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.72528782 |
| 55 | MYC_22102868_ChIP-Seq_BL_Human | 1.70615536 |
| 56 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.70314520 |
| 57 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.70182538 |
| 58 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.70099900 |
| 59 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.69169005 |
| 60 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.68480229 |
| 61 | MAF_26560356_Chip-Seq_TH2_Human | 1.66777051 |
| 62 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.66069657 |
| 63 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.63439066 |
| 64 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.62321176 |
| 65 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.62030273 |
| 66 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.61991558 |
| 67 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.61619811 |
| 68 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.60924375 |
| 69 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.58930239 |
| 70 | MAF_26560356_Chip-Seq_TH1_Human | 1.58116178 |
| 71 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.56576749 |
| 72 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54976296 |
| 73 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.54594720 |
| 74 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.53378958 |
| 75 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.52957182 |
| 76 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.50641123 |
| 77 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.48736065 |
| 78 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.48236601 |
| 79 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.47845250 |
| 80 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47033377 |
| 81 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.46198819 |
| 82 | KDM2B_26808549_Chip-Seq_K562_Human | 1.45597204 |
| 83 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.44860186 |
| 84 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.44647040 |
| 85 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.43762569 |
| 86 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.41551161 |
| 87 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.40918248 |
| 88 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.40452362 |
| 89 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.39768676 |
| 90 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.37418635 |
| 91 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.36762144 |
| 92 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.36499191 |
| 93 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.34633290 |
| 94 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.33974759 |
| 95 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.33589715 |
| 96 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.33566590 |
| 97 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.33400432 |
| 98 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.32886116 |
| 99 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.31517033 |
| 100 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.31435668 |
| 101 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.30110938 |
| 102 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.29459690 |
| 103 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.29212243 |
| 104 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.28887613 |
| 105 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.25749810 |
| 106 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.25597130 |
| 107 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.25189028 |
| 108 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.24099018 |
| 109 | SA1_27219007_Chip-Seq_Bcells_Human | 1.23981398 |
| 110 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.23693926 |
| 111 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.22256869 |
| 112 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.22224725 |
| 113 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.20962473 |
| 114 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.20150345 |
| 115 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.19709924 |
| 116 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.18632548 |
| 117 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.18201147 |
| 118 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.17856177 |
| 119 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.17560753 |
| 120 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.17282460 |
| 121 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.16915429 |
| 122 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.15980610 |
| 123 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.15872550 |
| 124 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.15786387 |
| 125 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.15286623 |
| 126 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.14986057 |
| 127 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.14133973 |
| 128 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.13481176 |
| 129 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.13323913 |
| 130 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.12553113 |
| 131 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.11463556 |
| 132 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.11029507 |
| 133 | * CTCF_21964334_Chip-Seq_Bcells_Human | 1.10911315 |
| 134 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.09880638 |
| 135 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.09310408 |
| 136 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.08952964 |
| 137 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.07826149 |
| 138 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.07745469 |
| 139 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.07550225 |
| 140 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07125688 |
| 141 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.06274362 |
| 142 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.05853534 |
| 143 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.04958997 |
| 144 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.04881111 |
| 145 | ATF3_27146783_Chip-Seq_COLON_Human | 1.03695463 |
| 146 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.03262042 |
| 147 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.02540026 |
| 148 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02532525 |
| 149 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.00841352 |
| 150 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.00330853 |
| 151 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.98429482 |
| 152 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.97920429 |
| 153 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.96531559 |
| 154 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.94061765 |
| 155 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.93150870 |
| 156 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.93112556 |
| 157 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.92895032 |
| 158 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.91423363 |
| 159 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91078196 |
| 160 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.91011101 |
| 161 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.88754012 |
| 162 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.88424748 |
| 163 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.86478195 |
| 164 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.86199276 |
| 165 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.84867867 |
| 166 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.83683486 |
| 167 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.80775791 |
| 168 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.80688803 |
| 169 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78129386 |
| 170 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77449579 |
| 171 | UTX_26944678_Chip-Seq_JUKART_Human | 0.74950840 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 5.55331918 |
| 2 | MP0010094_abnormal_chromosome_stability | 4.54551007 |
| 3 | MP0003111_abnormal_nucleus_morphology | 4.52292176 |
| 4 | MP0004957_abnormal_blastocyst_morpholog | 4.25780348 |
| 5 | MP0003077_abnormal_cell_cycle | 3.94282372 |
| 6 | MP0008057_abnormal_DNA_replication | 3.76996604 |
| 7 | MP0008058_abnormal_DNA_repair | 3.35260397 |
| 8 | MP0003705_abnormal_hypodermis_morpholog | 3.17912780 |
| 9 | MP0005058_abnormal_lysosome_morphology | 3.16895886 |
| 10 | MP0008007_abnormal_cellular_replicative | 3.11068894 |
| 11 | MP0002396_abnormal_hematopoietic_system | 2.89700143 |
| 12 | MP0004858_abnormal_nervous_system | 2.81385633 |
| 13 | MP0009278_abnormal_bone_marrow | 2.70050425 |
| 14 | MP0005451_abnormal_body_composition | 2.63840816 |
| 15 | MP0005076_abnormal_cell_differentiation | 2.63442379 |
| 16 | MP0008932_abnormal_embryonic_tissue | 2.62930296 |
| 17 | MP0000678_abnormal_parathyroid_gland | 2.62091939 |
| 18 | MP0001348_abnormal_lacrimal_gland | 2.55057043 |
| 19 | MP0000751_myopathy | 2.51311103 |
| 20 | MP0003786_premature_aging | 2.30747496 |
| 21 | MP0003172_abnormal_lysosome_physiology | 2.20936272 |
| 22 | MP0001730_embryonic_growth_arrest | 2.18687638 |
| 23 | MP0002249_abnormal_larynx_morphology | 2.17883944 |
| 24 | MP0003763_abnormal_thymus_physiology | 2.16495446 |
| 25 | MP0001849_ear_inflammation | 2.14955717 |
| 26 | MP0000350_abnormal_cell_proliferation | 2.13631540 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 2.06008599 |
| 28 | MP0000490_abnormal_crypts_of | 2.05288015 |
| 29 | MP0010352_gastrointestinal_tract_polyps | 1.98191927 |
| 30 | MP0004185_abnormal_adipocyte_glucose | 1.87988260 |
| 31 | MP0000003_abnormal_adipose_tissue | 1.82907961 |
| 32 | MP0003806_abnormal_nucleotide_metabolis | 1.72125867 |
| 33 | MP0004381_abnormal_hair_follicle | 1.71318413 |
| 34 | MP0000747_muscle_weakness | 1.71277723 |
| 35 | MP0003123_paternal_imprinting | 1.64938253 |
| 36 | MP0010307_abnormal_tumor_latency | 1.63945836 |
| 37 | MP0002019_abnormal_tumor_incidence | 1.63941928 |
| 38 | MP0004808_abnormal_hematopoietic_stem | 1.60325448 |
| 39 | MP0002398_abnormal_bone_marrow | 1.57866729 |
| 40 | MP0000313_abnormal_cell_death | 1.56149821 |
| 41 | MP0005075_abnormal_melanosome_morpholog | 1.55829718 |
| 42 | MP0001697_abnormal_embryo_size | 1.53819584 |
| 43 | MP0003718_maternal_effect | 1.53668637 |
| 44 | MP0002080_prenatal_lethality | 1.53390032 |
| 45 | MP0008877_abnormal_DNA_methylation | 1.52275373 |
| 46 | MP0002722_abnormal_immune_system | 1.49082547 |
| 47 | MP0000703_abnormal_thymus_morphology | 1.47544087 |
| 48 | MP0004947_skin_inflammation | 1.45826835 |
| 49 | MP0005380_embryogenesis_phenotype | 1.44092309 |
| 50 | MP0001672_abnormal_embryogenesis/_devel | 1.44092309 |
| 51 | MP0000689_abnormal_spleen_morphology | 1.42844654 |
| 52 | MP0005375_adipose_tissue_phenotype | 1.41619626 |
| 53 | MP0005671_abnormal_response_to | 1.40108401 |
| 54 | MP0000537_abnormal_urethra_morphology | 1.39667973 |
| 55 | MP0001545_abnormal_hematopoietic_system | 1.39450653 |
| 56 | MP0005397_hematopoietic_system_phenotyp | 1.39450653 |
| 57 | MP0005666_abnormal_adipose_tissue | 1.38142141 |
| 58 | MP0003329_amyloid_beta_deposits | 1.37018113 |
| 59 | MP0004233_abnormal_muscle_weight | 1.33623782 |
| 60 | MP0000685_abnormal_immune_system | 1.30416423 |
| 61 | MP0003984_embryonic_growth_retardation | 1.28887575 |
| 62 | MP0002429_abnormal_blood_cell | 1.27111067 |
| 63 | MP0001835_abnormal_antigen_presentation | 1.26158824 |
| 64 | MP0002088_abnormal_embryonic_growth/wei | 1.25774783 |
| 65 | MP0010030_abnormal_orbit_morphology | 1.23726595 |
| 66 | MP0003453_abnormal_keratinocyte_physiol | 1.23588445 |
| 67 | MP0003567_abnormal_fetal_cardiomyocyte | 1.21139524 |
| 68 | MP0000759_abnormal_skeletal_muscle | 1.19650574 |
| 69 | MP0002089_abnormal_postnatal_growth/wei | 1.17949703 |
| 70 | MP0001502_abnormal_circadian_rhythm | 1.17263536 |
| 71 | MP0000716_abnormal_immune_system | 1.17138832 |
| 72 | MP0002085_abnormal_embryonic_tissue | 1.16134625 |
| 73 | MP0000358_abnormal_cell_content/ | 1.16063733 |
| 74 | MP0002086_abnormal_extraembryonic_tissu | 1.12223191 |
| 75 | MP0001800_abnormal_humoral_immune | 1.11904985 |
| 76 | MP0002132_abnormal_respiratory_system | 1.09316454 |
| 77 | MP0005330_cardiomyopathy | 1.09047799 |
| 78 | MP0002933_joint_inflammation | 1.08578916 |
| 79 | MP0003646_muscle_fatigue | 1.06762914 |
| 80 | MP0001346_abnormal_lacrimal_gland | 1.06677723 |
| 81 | MP0002420_abnormal_adaptive_immunity | 1.06439591 |
| 82 | MP0003186_abnormal_redox_activity | 1.05975622 |
| 83 | MP0009384_cardiac_valve_regurgitation | 1.05538010 |
| 84 | MP0001819_abnormal_immune_cell | 1.05140017 |
| 85 | MP0001853_heart_inflammation | 1.05116962 |
| 86 | MP0009379_abnormal_foot_pigmentation | 1.04773431 |
| 87 | MP0002210_abnormal_sex_determination | 1.04393669 |
| 88 | MP0006292_abnormal_olfactory_placode | 1.03469537 |
| 89 | MP0000750_abnormal_muscle_regeneration | 1.02646646 |
| 90 | MP0002084_abnormal_developmental_patter | 1.01483458 |
| 91 | MP0002254_reproductive_system_inflammat | 1.01217334 |
| 92 | MP0003315_abnormal_perineum_morphology | 1.01087374 |
| 93 | MP0003436_decreased_susceptibility_to | 1.00174677 |
| 94 | MP0005083_abnormal_biliary_tract | 0.99007171 |
| 95 | MP0002452_abnormal_antigen_presenting | 0.98938831 |
| 96 | MP0001661_extended_life_span | 0.98381001 |
| 97 | MP0000566_synostosis | 0.98024422 |
| 98 | MP0006054_spinal_hemorrhage | 0.97778906 |
| 99 | MP0004197_abnormal_fetal_growth/weight/ | 0.97674155 |
| 100 | MP0000858_altered_metastatic_potential | 0.95918195 |
| 101 | MP0002723_abnormal_immune_serum | 0.95099488 |
| 102 | MP0009785_altered_susceptibility_to | 0.94818483 |
| 103 | MP0008995_early_reproductive_senescence | 0.94314445 |
| 104 | MP0001145_abnormal_male_reproductive | 0.93943878 |
| 105 | MP0008260_abnormal_autophagy | 0.93406027 |
| 106 | MP0009672_abnormal_birth_weight | 0.92853250 |
| 107 | MP0000681_abnormal_thyroid_gland | 0.92792373 |
| 108 | MP0002970_abnormal_white_adipose | 0.92589338 |
| 109 | MP0003303_peritoneal_inflammation | 0.90540727 |
| 110 | MP0005409_darkened_coat_color | 0.89899898 |
| 111 | MP0002160_abnormal_reproductive_system | 0.89845101 |
| 112 | MP0005174_abnormal_tail_pigmentation | 0.89762135 |
| 113 | MP0000733_abnormal_muscle_development | 0.88719224 |
| 114 | MP0003221_abnormal_cardiomyocyte_apopto | 0.88716774 |
| 115 | MP0001293_anophthalmia | 0.88664496 |
| 116 | MP0009931_abnormal_skin_appearance | 0.88417834 |
| 117 | MP0006035_abnormal_mitochondrial_morpho | 0.88189386 |
| 118 | MP0002166_altered_tumor_susceptibility | 0.86584580 |
| 119 | MP0006036_abnormal_mitochondrial_physio | 0.85567745 |
| 120 | MP0005023_abnormal_wound_healing | 0.84512997 |
| 121 | MP0004087_abnormal_muscle_fiber | 0.84510652 |
| 122 | MP0002405_respiratory_system_inflammati | 0.83699278 |
| 123 | MP0005025_abnormal_response_to | 0.82385786 |
| 124 | MP0004130_abnormal_muscle_cell | 0.81215829 |
| 125 | MP0005387_immune_system_phenotype | 0.80269882 |
| 126 | MP0001790_abnormal_immune_system | 0.80269882 |
| 127 | MP0005000_abnormal_immune_tolerance | 0.79012145 |
| 128 | MP0001929_abnormal_gametogenesis | 0.78732947 |
| 129 | MP0003879_abnormal_hair_cell | 0.78693830 |
| 130 | MP0005384_cellular_phenotype | 0.78636300 |
| 131 | MP0000015_abnormal_ear_pigmentation | 0.78612912 |
| 132 | MP0002006_tumorigenesis | 0.78292891 |
| 133 | MP0010155_abnormal_intestine_physiology | 0.78255949 |
| 134 | MP0005670_abnormal_white_adipose | 0.77906492 |
| 135 | MP0003566_abnormal_cell_adhesion | 0.77581816 |
| 136 | MP0002653_abnormal_ependyma_morphology | 0.76408347 |
| 137 | MP0000653_abnormal_sex_gland | 0.76188957 |
| 138 | MP0000477_abnormal_intestine_morphology | 0.75205167 |
| 139 | MP0008961_abnormal_basal_metabolism | 0.75085536 |
| 140 | MP0000465_gastrointestinal_hemorrhage | 0.73728973 |
| 141 | MP0001958_emphysema | 0.73252448 |
| 142 | MP0002095_abnormal_skin_pigmentation | 0.72437436 |
| 143 | MP0005621_abnormal_cell_physiology | 0.72094332 |
| 144 | MP0004859_abnormal_synaptic_plasticity | 0.71819300 |
| 145 | MP0004145_abnormal_muscle_electrophysio | 0.70532828 |
| 146 | MP0004510_myositis | 0.69739989 |
| 147 | MP0005389_reproductive_system_phenotype | 0.65891617 |
| 148 | MP0005501_abnormal_skin_physiology | 0.64861377 |
| 149 | MP0001873_stomach_inflammation | 0.64113757 |
| 150 | MP0005464_abnormal_platelet_physiology | 0.63456591 |
| 151 | MP0001119_abnormal_female_reproductive | 0.62854070 |
| 152 | MP0001764_abnormal_homeostasis | 0.59180344 |
| 153 | MP0003866_abnormal_defecation | 0.57442720 |
| 154 | MP0002148_abnormal_hypersensitivity_rea | 0.56215186 |
| 155 | MP0009840_abnormal_foam_cell | 0.54533894 |
| 156 | MP0003890_abnormal_embryonic-extraembry | 0.53460976 |
| 157 | MP0001845_abnormal_inflammatory_respons | 0.52421285 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Birth length less than 3rd percentile (HP:0003561) | 4.96063856 |
| 2 | Reticulocytopenia (HP:0001896) | 4.77582286 |
| 3 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.59148350 |
| 4 | Aplastic anemia (HP:0001915) | 4.48122801 |
| 5 | Abnormal number of erythroid precursors (HP:0012131) | 4.47706917 |
| 6 | Testicular atrophy (HP:0000029) | 4.05341633 |
| 7 | Hyperacusis (HP:0010780) | 3.94617534 |
| 8 | Myopathic facies (HP:0002058) | 3.89497977 |
| 9 | Breast hypoplasia (HP:0003187) | 3.84538814 |
| 10 | Oral leukoplakia (HP:0002745) | 3.65723294 |
| 11 | Stridor (HP:0010307) | 3.49724147 |
| 12 | Cerebral hypomyelination (HP:0006808) | 3.46859158 |
| 13 | Ragged-red muscle fibers (HP:0003200) | 3.43454121 |
| 14 | Colon cancer (HP:0003003) | 3.42501403 |
| 15 | Macrocytic anemia (HP:0001972) | 3.42092449 |
| 16 | Increased connective tissue (HP:0009025) | 3.37115744 |
| 17 | Broad face (HP:0000283) | 3.33818774 |
| 18 | Rough bone trabeculation (HP:0100670) | 3.25252333 |
| 19 | Truncus arteriosus (HP:0001660) | 3.25247302 |
| 20 | Abnormality of the anterior horn cell (HP:0006802) | 3.22439561 |
| 21 | Degeneration of anterior horn cells (HP:0002398) | 3.22439561 |
| 22 | Obstructive sleep apnea (HP:0002870) | 3.20462561 |
| 23 | Pallor (HP:0000980) | 3.16725326 |
| 24 | Chromsome breakage (HP:0040012) | 3.13527125 |
| 25 | Selective tooth agenesis (HP:0001592) | 3.13475236 |
| 26 | Carpal bone hypoplasia (HP:0001498) | 3.09616649 |
| 27 | Microretrognathia (HP:0000308) | 3.00319052 |
| 28 | Upper limb amyotrophy (HP:0009129) | 2.97867584 |
| 29 | Distal upper limb amyotrophy (HP:0007149) | 2.97867584 |
| 30 | 11 pairs of ribs (HP:0000878) | 2.96334525 |
| 31 | Broad distal phalanx of finger (HP:0009836) | 2.96162387 |
| 32 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.94690635 |
| 33 | Ulnar bowing (HP:0003031) | 2.93998051 |
| 34 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.92889913 |
| 35 | Thrombocytosis (HP:0001894) | 2.91202026 |
| 36 | Patellar aplasia (HP:0006443) | 2.86667541 |
| 37 | Ependymoma (HP:0002888) | 2.81857076 |
| 38 | Thin bony cortex (HP:0002753) | 2.79230636 |
| 39 | Agnosia (HP:0010524) | 2.78166838 |
| 40 | Abnormality of the preputium (HP:0100587) | 2.77112507 |
| 41 | Cholecystitis (HP:0001082) | 2.75932720 |
| 42 | Abnormal gallbladder physiology (HP:0012438) | 2.75932720 |
| 43 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.75355052 |
| 44 | Annular pancreas (HP:0001734) | 2.73125381 |
| 45 | Meckel diverticulum (HP:0002245) | 2.70895549 |
| 46 | Biconcave vertebral bodies (HP:0004586) | 2.70022501 |
| 47 | Multiple enchondromatosis (HP:0005701) | 2.69713934 |
| 48 | Medulloblastoma (HP:0002885) | 2.69633426 |
| 49 | Absent thumb (HP:0009777) | 2.66868039 |
| 50 | Trismus (HP:0000211) | 2.62303363 |
| 51 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.61964937 |
| 52 | Hypertensive crisis (HP:0100735) | 2.60751222 |
| 53 | Abnormality of the ileum (HP:0001549) | 2.60031062 |
| 54 | Colitis (HP:0002583) | 2.58257732 |
| 55 | Distal lower limb amyotrophy (HP:0008944) | 2.55812375 |
| 56 | IgM deficiency (HP:0002850) | 2.54752938 |
| 57 | Abnormality of the fingertips (HP:0001211) | 2.53108494 |
| 58 | Abnormality of chromosome stability (HP:0003220) | 2.50838689 |
| 59 | Atelectasis (HP:0100750) | 2.50652788 |
| 60 | Myelodysplasia (HP:0002863) | 2.47681756 |
| 61 | Hyperthyroidism (HP:0000836) | 2.47168770 |
| 62 | Neoplasm of the pancreas (HP:0002894) | 2.46630896 |
| 63 | Premature graying of hair (HP:0002216) | 2.43952032 |
| 64 | Bone marrow hypocellularity (HP:0005528) | 2.43333750 |
| 65 | Pancytopenia (HP:0001876) | 2.42982039 |
| 66 | Difficulty climbing stairs (HP:0003551) | 2.42981686 |
| 67 | Seborrheic dermatitis (HP:0001051) | 2.40715000 |
| 68 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.39767538 |
| 69 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.39767538 |
| 70 | Premature ovarian failure (HP:0008209) | 2.39602193 |
| 71 | Muscle fiber atrophy (HP:0100295) | 2.39129718 |
| 72 | Insomnia (HP:0100785) | 2.37297089 |
| 73 | Progressive external ophthalmoplegia (HP:0000590) | 2.34500801 |
| 74 | Lymphoma (HP:0002665) | 2.34458385 |
| 75 | Hemorrhage of the eye (HP:0011885) | 2.33966242 |
| 76 | Achilles tendon contracture (HP:0001771) | 2.33557443 |
| 77 | Type I transferrin isoform profile (HP:0003642) | 2.33445186 |
| 78 | Easy fatigability (HP:0003388) | 2.33079332 |
| 79 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.33038845 |
| 80 | Long palpebral fissure (HP:0000637) | 2.30308397 |
| 81 | Secondary amenorrhea (HP:0000869) | 2.29526627 |
| 82 | Hand muscle atrophy (HP:0009130) | 2.28779247 |
| 83 | Exercise-induced myalgia (HP:0003738) | 2.27112367 |
| 84 | J-shaped sella turcica (HP:0002680) | 2.26580430 |
| 85 | Type 2 muscle fiber atrophy (HP:0003554) | 2.26450493 |
| 86 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.25794530 |
| 87 | Poikiloderma (HP:0001029) | 2.25154054 |
| 88 | Abnormal trabecular bone morphology (HP:0100671) | 2.24561395 |
| 89 | Impulsivity (HP:0100710) | 2.24138358 |
| 90 | Basal cell carcinoma (HP:0002671) | 2.24055111 |
| 91 | Reticulocytosis (HP:0001923) | 2.23972687 |
| 92 | Megaloblastic anemia (HP:0001889) | 2.20558638 |
| 93 | Pointed chin (HP:0000307) | 2.20522502 |
| 94 | Vertebral compression fractures (HP:0002953) | 2.19035452 |
| 95 | Entropion (HP:0000621) | 2.18901311 |
| 96 | Slender long bone (HP:0003100) | 2.18634787 |
| 97 | Rectal prolapse (HP:0002035) | 2.18385928 |
| 98 | Abnormality of the aortic arch (HP:0012303) | 2.16899406 |
| 99 | Duodenal stenosis (HP:0100867) | 2.16455735 |
| 100 | Small intestinal stenosis (HP:0012848) | 2.16455735 |
| 101 | Cervical subluxation (HP:0003308) | 2.15172545 |
| 102 | Deep palmar crease (HP:0006191) | 2.12407753 |
| 103 | Increased serum lactate (HP:0002151) | 2.12317247 |
| 104 | Abnormality of DNA repair (HP:0003254) | 2.12252927 |
| 105 | Horseshoe kidney (HP:0000085) | 2.11403702 |
| 106 | Cellular immunodeficiency (HP:0005374) | 2.10968860 |
| 107 | Tracheoesophageal fistula (HP:0002575) | 2.10281423 |
| 108 | External ophthalmoplegia (HP:0000544) | 2.10279741 |
| 109 | Joint stiffness (HP:0001387) | 2.09312674 |
| 110 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.09148306 |
| 111 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.08627770 |
| 112 | Increased cerebral lipofuscin (HP:0011813) | 2.08442054 |
| 113 | Poor head control (HP:0002421) | 2.07068293 |
| 114 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.07016620 |
| 115 | Cleft eyelid (HP:0000625) | 2.06353795 |
| 116 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.05559156 |
| 117 | Petechiae (HP:0000967) | 2.05213222 |
| 118 | Amaurosis fugax (HP:0100576) | 2.03460885 |
| 119 | Progressive muscle weakness (HP:0003323) | 2.03352559 |
| 120 | Diaphragmatic weakness (HP:0009113) | 2.02937105 |
| 121 | Abnormality of the thoracic spine (HP:0100711) | 2.02894117 |
| 122 | Rhabdomyosarcoma (HP:0002859) | 2.02454616 |
| 123 | Gastrointestinal dysmotility (HP:0002579) | 2.01672384 |
| 124 | CNS hypomyelination (HP:0003429) | 2.01371140 |
| 125 | Thoracic kyphosis (HP:0002942) | 2.00732756 |
| 126 | Sloping forehead (HP:0000340) | 2.00276669 |
| 127 | Disproportionate tall stature (HP:0001519) | 1.99938526 |
| 128 | Gastrointestinal inflammation (HP:0004386) | 1.99662831 |
| 129 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.98915842 |
| 130 | Bowel incontinence (HP:0002607) | 1.98651048 |
| 131 | Absent radius (HP:0003974) | 1.98042660 |
| 132 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.97804980 |
| 133 | Microvesicular hepatic steatosis (HP:0001414) | 1.97164984 |
| 134 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.96216048 |
| 135 | Thin ribs (HP:0000883) | 1.96002058 |
| 136 | Hepatocellular necrosis (HP:0001404) | 1.95220235 |
| 137 | Bronchomalacia (HP:0002780) | 1.94537252 |
| 138 | Abnormality of the Achilles tendon (HP:0005109) | 1.94148333 |
| 139 | Optic nerve coloboma (HP:0000588) | 1.91879758 |
| 140 | Squamous cell carcinoma (HP:0002860) | 1.91871033 |
| 141 | Abnormality of reticulocytes (HP:0004312) | 1.91617133 |
| 142 | IgG deficiency (HP:0004315) | 1.91456222 |
| 143 | Exertional dyspnea (HP:0002875) | 1.91040167 |
| 144 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.90969054 |
| 145 | Triphalangeal thumb (HP:0001199) | 1.90819060 |
| 146 | Metaphyseal cupping (HP:0003021) | 1.89838368 |
| 147 | Increased variability in muscle fiber diameter (HP:0003557) | 1.87872343 |
| 148 | Glossoptosis (HP:0000162) | 1.87225858 |
| 149 | Missing ribs (HP:0000921) | 1.87027263 |
| 150 | Abnormal large intestine physiology (HP:0012700) | 1.87020911 |
| 151 | Abnormal lung lobation (HP:0002101) | 1.86271350 |
| 152 | Premature skin wrinkling (HP:0100678) | 1.84798625 |
| 153 | Emphysema (HP:0002097) | 1.84586831 |
| 154 | Bowed forearm bones (HP:0003956) | 1.84307720 |
| 155 | Bowing of the arm (HP:0006488) | 1.84307720 |
| 156 | Dysmetric saccades (HP:0000641) | 1.83535494 |
| 157 | Cholelithiasis (HP:0001081) | 1.83325192 |
| 158 | Turricephaly (HP:0000262) | 1.82952814 |
| 159 | Abnormality of T cell physiology (HP:0011840) | 1.82566025 |
| 160 | Abnormal number of incisors (HP:0011064) | 1.81721168 |
| 161 | Tongue fasciculations (HP:0001308) | 1.81527326 |
| 162 | Abnormality of T cells (HP:0002843) | 1.80606346 |
| 163 | Absent forearm bone (HP:0003953) | 1.80374007 |
| 164 | Aplasia involving forearm bones (HP:0009822) | 1.80374007 |
| 165 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.78494457 |
| 166 | Severe visual impairment (HP:0001141) | 1.78026680 |
| 167 | Abnormality of the duodenum (HP:0002246) | 1.77678091 |
| 168 | Sparse eyelashes (HP:0000653) | 1.77085871 |
| 169 | Patellar dislocation (HP:0002999) | 1.76723071 |
| 170 | Hypoparathyroidism (HP:0000829) | 1.76595082 |
| 171 | Personality changes (HP:0000751) | 1.75003468 |
| 172 | Ankle clonus (HP:0011448) | 1.74861934 |
| 173 | Abnormal spermatogenesis (HP:0008669) | 1.74484681 |
| 174 | Absent epiphyses (HP:0010577) | 1.73494994 |
| 175 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.73494994 |
| 176 | Distal lower limb muscle weakness (HP:0009053) | 1.73222751 |
| 177 | Mitral regurgitation (HP:0001653) | 1.73169052 |
| 178 | Delayed epiphyseal ossification (HP:0002663) | 1.71192979 |
| 179 | Dysautonomia (HP:0002459) | 1.70495690 |
| 180 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.70477277 |
| 181 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.69828702 |
| 182 | Lower limb amyotrophy (HP:0007210) | 1.68067987 |
| 183 | Cellulitis (HP:0100658) | 1.67394411 |
| 184 | Dislocated radial head (HP:0003083) | 1.67056522 |
| 185 | Increased IgE level (HP:0003212) | 1.66500645 |
| 186 | Cerebral aneurysm (HP:0004944) | 1.65897611 |
| 187 | Obstructive lung disease (HP:0006536) | 1.63749774 |
| 188 | Chronic obstructive pulmonary disease (HP:0006510) | 1.63749774 |
| 189 | Elfin facies (HP:0004428) | 1.63082489 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 5.36242245 |
| 2 | BUB1 | 4.89443336 |
| 3 | WEE1 | 4.38027491 |
| 4 | STK16 | 3.64690710 |
| 5 | CDC7 | 3.19432559 |
| 6 | SMG1 | 3.09364267 |
| 7 | ERN1 | 2.93479560 |
| 8 | EIF2AK1 | 2.88420375 |
| 9 | ICK | 2.83793230 |
| 10 | NME2 | 2.70098513 |
| 11 | TSSK6 | 2.70091842 |
| 12 | SIK1 | 2.58607423 |
| 13 | NEK2 | 2.48661817 |
| 14 | TLK1 | 2.39108615 |
| 15 | PRPF4B | 2.32381831 |
| 16 | SRPK1 | 2.29364109 |
| 17 | TESK2 | 2.29028784 |
| 18 | ACVR1B | 2.08529802 |
| 19 | SIK2 | 1.95959482 |
| 20 | RIPK1 | 1.93173363 |
| 21 | KDR | 1.82126037 |
| 22 | BRSK2 | 1.77658961 |
| 23 | IRAK3 | 1.74712055 |
| 24 | TTK | 1.70360714 |
| 25 | NEK1 | 1.70208883 |
| 26 | MAP4K1 | 1.69879599 |
| 27 | EIF2AK3 | 1.68869687 |
| 28 | PLK1 | 1.68580400 |
| 29 | RPS6KB2 | 1.68247716 |
| 30 | MAP2K6 | 1.68182045 |
| 31 | VRK1 | 1.67044581 |
| 32 | TNK2 | 1.66786316 |
| 33 | PLK4 | 1.63193859 |
| 34 | EPHA2 | 1.58600339 |
| 35 | MARK2 | 1.54518950 |
| 36 | PIM2 | 1.54405086 |
| 37 | PRKD3 | 1.50912568 |
| 38 | PASK | 1.50506949 |
| 39 | CDK7 | 1.46018426 |
| 40 | AURKB | 1.44910020 |
| 41 | SCYL2 | 1.44864746 |
| 42 | ATR | 1.44398061 |
| 43 | DYRK3 | 1.43859884 |
| 44 | CCNB1 | 1.38085797 |
| 45 | TTN | 1.36145206 |
| 46 | FGFR4 | 1.34587355 |
| 47 | PRKD2 | 1.31500055 |
| 48 | AURKA | 1.22273758 |
| 49 | BCKDK | 1.22131190 |
| 50 | EPHB1 | 1.21335573 |
| 51 | BRSK1 | 1.20191783 |
| 52 | MAP3K13 | 1.17488011 |
| 53 | MKNK1 | 1.17450134 |
| 54 | MAPK15 | 1.17381505 |
| 55 | RPS6KA4 | 1.16637581 |
| 56 | MAP3K7 | 1.15000632 |
| 57 | PTK6 | 1.14322631 |
| 58 | PLK3 | 1.13879732 |
| 59 | PAK4 | 1.13721689 |
| 60 | BMX | 1.13688839 |
| 61 | EEF2K | 1.12958348 |
| 62 | MAP3K8 | 1.12515455 |
| 63 | TGFBR1 | 1.12379693 |
| 64 | CAMKK1 | 1.12088565 |
| 65 | FLT3 | 1.11213295 |
| 66 | CDC42BPA | 1.10810812 |
| 67 | MTOR | 1.06783201 |
| 68 | CHEK2 | 1.05112207 |
| 69 | CDK4 | 1.01830561 |
| 70 | ZAK | 1.00038929 |
| 71 | ZAP70 | 0.98507242 |
| 72 | ARAF | 0.96928898 |
| 73 | BLK | 0.96352117 |
| 74 | MAPK11 | 0.95795793 |
| 75 | CHEK1 | 0.95212784 |
| 76 | TYRO3 | 0.94912610 |
| 77 | MAP3K11 | 0.93823539 |
| 78 | NME1 | 0.93079797 |
| 79 | RIPK4 | 0.91176838 |
| 80 | STK10 | 0.88173608 |
| 81 | PDPK1 | 0.86550940 |
| 82 | LMTK2 | 0.86295423 |
| 83 | RPS6KA2 | 0.85596358 |
| 84 | TESK1 | 0.84538269 |
| 85 | BTK | 0.84083333 |
| 86 | PIM1 | 0.83948895 |
| 87 | MKNK2 | 0.83814534 |
| 88 | MAP2K3 | 0.82746041 |
| 89 | RPS6KL1 | 0.80479957 |
| 90 | RPS6KC1 | 0.80479957 |
| 91 | MST1R | 0.79700681 |
| 92 | TEC | 0.78405753 |
| 93 | KIT | 0.78172037 |
| 94 | IRAK4 | 0.77384485 |
| 95 | LRRK2 | 0.76742059 |
| 96 | MAPK12 | 0.76178938 |
| 97 | CAMK1D | 0.76075600 |
| 98 | BRAF | 0.75687869 |
| 99 | MAP3K10 | 0.72793028 |
| 100 | RPS6KA6 | 0.70530445 |
| 101 | HIPK2 | 0.70190962 |
| 102 | TAOK1 | 0.69601777 |
| 103 | PRKCI | 0.68858828 |
| 104 | PKN2 | 0.68388798 |
| 105 | TAOK2 | 0.67950429 |
| 106 | STK4 | 0.67446589 |
| 107 | CSNK2A1 | 0.66559955 |
| 108 | TYK2 | 0.66305271 |
| 109 | MAPKAPK3 | 0.65979592 |
| 110 | CSNK2A2 | 0.65924479 |
| 111 | JAK3 | 0.64932364 |
| 112 | KSR2 | 0.63692686 |
| 113 | CDK2 | 0.63574526 |
| 114 | CDK8 | 0.63521525 |
| 115 | PAK1 | 0.62884065 |
| 116 | TXK | 0.61773455 |
| 117 | CLK1 | 0.59118489 |
| 118 | ATM | 0.58888032 |
| 119 | MAP3K1 | 0.58657365 |
| 120 | EIF2AK2 | 0.50807778 |
| 121 | PDK1 | 0.50173568 |
| 122 | MAP3K6 | 0.49257659 |
| 123 | CSF1R | 0.48482446 |
| 124 | SIK3 | 0.47659131 |
| 125 | MAP3K3 | 0.46871313 |
| 126 | NLK | 0.45987720 |
| 127 | PBK | 0.45144197 |
| 128 | RPS6KA5 | 0.42778981 |
| 129 | PTK2 | 0.42765788 |
| 130 | ILK | 0.41798923 |
| 131 | DYRK1B | 0.41719002 |
| 132 | NEK9 | 0.40844064 |
| 133 | CDK1 | 0.40786713 |
| 134 | LYN | 0.40531031 |
| 135 | GRK6 | 0.39840564 |
| 136 | RET | 0.39387144 |
| 137 | SYK | 0.38794279 |
| 138 | RPS6KA1 | 0.38715344 |
| 139 | WNK4 | 0.35590660 |
| 140 | AKT2 | 0.33401548 |
| 141 | IKBKB | 0.33009129 |
| 142 | DYRK2 | 0.32862674 |
| 143 | LCK | 0.32083375 |
| 144 | PRKAA1 | 0.31869171 |
| 145 | TBK1 | 0.31584589 |
| 146 | CDK12 | 0.31345713 |
| 147 | MAPK8 | 0.31085572 |
| 148 | PRKCH | 0.30892759 |
| 149 | ALK | 0.30301157 |
| 150 | ITK | 0.29869805 |
| 151 | PRKD1 | 0.29854481 |
| 152 | MAP2K2 | 0.29538712 |
| 153 | MST4 | 0.28883207 |
| 154 | PHKG2 | 0.28523051 |
| 155 | MATK | 0.28006647 |
| 156 | PDK3 | 0.25932309 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 5.16548572 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 4.26809630 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.85823809 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 3.78997824 |
| 5 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.46223366 |
| 6 | RNA polymerase_Homo sapiens_hsa03020 | 3.21980665 |
| 7 | Base excision repair_Homo sapiens_hsa03410 | 3.15598775 |
| 8 | Spliceosome_Homo sapiens_hsa03040 | 3.12145560 |
| 9 | Homologous recombination_Homo sapiens_hsa03440 | 2.95566154 |
| 10 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.84766797 |
| 11 | RNA transport_Homo sapiens_hsa03013 | 2.82605805 |
| 12 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.60579689 |
| 13 | Notch signaling pathway_Homo sapiens_hsa04330 | 2.59324511 |
| 14 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.54323496 |
| 15 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.43903922 |
| 16 | Cell cycle_Homo sapiens_hsa04110 | 2.30271624 |
| 17 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.99736485 |
| 18 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.99722894 |
| 19 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.92078708 |
| 20 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.91212397 |
| 21 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.67552781 |
| 22 | RNA degradation_Homo sapiens_hsa03018 | 1.66942283 |
| 23 | Basal transcription factors_Homo sapiens_hsa03022 | 1.56935422 |
| 24 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.56006887 |
| 25 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.52775401 |
| 26 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.46231394 |
| 27 | Lysine degradation_Homo sapiens_hsa00310 | 1.44276887 |
| 28 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.43310746 |
| 29 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.31642680 |
| 30 | Purine metabolism_Homo sapiens_hsa00230 | 1.31593513 |
| 31 | Sulfur relay system_Homo sapiens_hsa04122 | 1.28601859 |
| 32 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.26174836 |
| 33 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.22890079 |
| 34 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.18460677 |
| 35 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.16523094 |
| 36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.14956741 |
| 37 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.13780424 |
| 38 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.11698989 |
| 39 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.11170870 |
| 40 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.10815922 |
| 41 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.08432273 |
| 42 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.08269065 |
| 43 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.05875548 |
| 44 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.05651758 |
| 45 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.01319187 |
| 46 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.99528375 |
| 47 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.98819553 |
| 48 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.96889686 |
| 49 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.95563067 |
| 50 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.95021748 |
| 51 | Protein export_Homo sapiens_hsa03060 | 0.93336575 |
| 52 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.92018845 |
| 53 | Prion diseases_Homo sapiens_hsa05020 | 0.88055173 |
| 54 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.87407418 |
| 55 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.86848869 |
| 56 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.86476801 |
| 57 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.84099105 |
| 58 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.83871296 |
| 59 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.83527568 |
| 60 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.81740850 |
| 61 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.80954452 |
| 62 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.80131295 |
| 63 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.78326567 |
| 64 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.77558846 |
| 65 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.77203058 |
| 66 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.76134965 |
| 67 | Hepatitis C_Homo sapiens_hsa05160 | 0.75984654 |
| 68 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.75361816 |
| 69 | Insulin resistance_Homo sapiens_hsa04931 | 0.74274361 |
| 70 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.71113424 |
| 71 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.69254969 |
| 72 | Endometrial cancer_Homo sapiens_hsa05213 | 0.68144174 |
| 73 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.68134434 |
| 74 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.66903896 |
| 75 | Lysosome_Homo sapiens_hsa04142 | 0.66040984 |
| 76 | Legionellosis_Homo sapiens_hsa05134 | 0.65042212 |
| 77 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.65039655 |
| 78 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.64618549 |
| 79 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.63866280 |
| 80 | HTLV-I infection_Homo sapiens_hsa05166 | 0.63471025 |
| 81 | Glioma_Homo sapiens_hsa05214 | 0.62916572 |
| 82 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.61143570 |
| 83 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.60080737 |
| 84 | Measles_Homo sapiens_hsa05162 | 0.58460673 |
| 85 | Endocytosis_Homo sapiens_hsa04144 | 0.57458358 |
| 86 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.53931144 |
| 87 | Carbon metabolism_Homo sapiens_hsa01200 | 0.53681746 |
| 88 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.53242014 |
| 89 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.51365135 |
| 90 | Thyroid cancer_Homo sapiens_hsa05216 | 0.50497689 |
| 91 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.50293996 |
| 92 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.49957996 |
| 93 | Shigellosis_Homo sapiens_hsa05131 | 0.49756696 |
| 94 | Apoptosis_Homo sapiens_hsa04210 | 0.49243776 |
| 95 | Galactose metabolism_Homo sapiens_hsa00052 | 0.48742081 |
| 96 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.48659186 |
| 97 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.48465002 |
| 98 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.46860504 |
| 99 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.46555552 |
| 100 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.45991222 |
| 101 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.44131618 |
| 102 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.43302331 |
| 103 | Huntingtons disease_Homo sapiens_hsa05016 | 0.42637773 |
| 104 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.42277356 |
| 105 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41491871 |
| 106 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.40058935 |
| 107 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.39864483 |
| 108 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.39350761 |
| 109 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.39076742 |
| 110 | Parkinsons disease_Homo sapiens_hsa05012 | 0.38620482 |
| 111 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.38465543 |
| 112 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.38034608 |
| 113 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.37806946 |
| 114 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.36688606 |
| 115 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.36513431 |
| 116 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.36419116 |
| 117 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.35770775 |
| 118 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35232443 |
| 119 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.33462416 |
| 120 | Hepatitis B_Homo sapiens_hsa05161 | 0.33108309 |
| 121 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.32862670 |
| 122 | Influenza A_Homo sapiens_hsa05164 | 0.30416972 |
| 123 | Allograft rejection_Homo sapiens_hsa05330 | 0.29386395 |
| 124 | Other glycan degradation_Homo sapiens_hsa00511 | 0.28237217 |
| 125 | Metabolic pathways_Homo sapiens_hsa01100 | 0.27551439 |
| 126 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.26854198 |
| 127 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.24231300 |
| 128 | Leishmaniasis_Homo sapiens_hsa05140 | 0.22962274 |
| 129 | Bladder cancer_Homo sapiens_hsa05219 | 0.22663806 |
| 130 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.22530207 |
| 131 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.21761077 |
| 132 | Alcoholism_Homo sapiens_hsa05034 | 0.21019096 |
| 133 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.19145195 |
| 134 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.18552178 |
| 135 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.18541149 |
| 136 | Viral myocarditis_Homo sapiens_hsa05416 | 0.18369721 |
| 137 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.17736835 |
| 138 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.17022102 |
| 139 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.16799378 |
| 140 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.16740770 |
| 141 | Colorectal cancer_Homo sapiens_hsa05210 | 0.16354116 |
| 142 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.16070993 |
| 143 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.15951752 |
| 144 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.14645940 |
| 145 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.13736964 |
| 146 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.12763590 |
| 147 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.11002759 |
| 148 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.10706253 |
| 149 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.10574016 |

